These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38655139)

  • 1. Editorial: Linking cellular metabolism to hematological malignancies, volume II.
    Liu Z; Yu J; Zhao ZJ; Shi H; Kashyap MK
    Front Oncol; 2024; 14():1387249. PubMed ID: 38655139
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies.
    Zhao Y; Huang Z; Peng H
    Front Oncol; 2021; 11():743006. PubMed ID: 34778060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From iron chelation to overload as a therapeutic strategy to induce ferroptosis in hematologic malignancies.
    Li J; Zhang W
    Hematology; 2022 Dec; 27(1):1163-1170. PubMed ID: 36222350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis: Redox Imbalance and Hematological Tumorigenesis.
    Lan H; Gao Y; Zhao Z; Mei Z; Wang F
    Front Oncol; 2022; 12():834681. PubMed ID: 35155264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Linking cellular metabolism to hematological malignancies.
    He X; Kashyap MK; Zhao ZJ; Yu J; Shi H
    Front Oncol; 2022; 12():1077358. PubMed ID: 36439481
    [No Abstract]   [Full Text] [Related]  

  • 6. Ferroptosis in hematological malignant tumors.
    Liu Y; Du Z; Huang J; Li T; Zhang J; Li Y; Yi W; Chen C
    Front Oncol; 2023; 13():1127526. PubMed ID: 37139157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy.
    Zhang L; Chang N; Liu J; Liu Z; Wu Y; Sui L; Chen W
    Front Oncol; 2022; 12():987499. PubMed ID: 36106108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism.
    Zhang J; Liu Y; Li Q; Xu A; Hu Y; Sun C
    Biomed Pharmacother; 2022 Apr; 148():112747. PubMed ID: 35240523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach.
    Zhou Q; Li T; Qin Q; Huang X; Wang Y
    Front Genet; 2022; 13():1039951. PubMed ID: 36406116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence.
    Logie E; Van Puyvelde B; Cuypers B; Schepers A; Berghmans H; Verdonck J; Laukens K; Godderis L; Dhaenens M; Deforce D; Vanden Berghe W
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of ferroptosis and its roles in leukemia.
    Chen Z; Zheng S; Han J; Fu L; Fu J; Zhang Z; Hong P; Feng W
    Front Oncol; 2023; 13():1308869. PubMed ID: 38125948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-Expressed GATA-1
    Trombetti S; Iaccarino N; Riccio P; Sessa R; Catapano R; Salvatore M; Luka S; de Nicola S; Izzo P; Roperto S; Maddalena P; Randazzo A; Grosso M
    Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted single-cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis-resistant state in hematologic malignancies.
    Shen X; Dong P; Kong J; Sun N; Wang F; Sang L; Xu Y; Zhang M; Chen X; Guo R; Wang S; Lin Q; Jiang Z; Xu S; Zhang C; Bian Z; Wang W; Guo R
    Cell Biochem Funct; 2023 Dec; 41(8):1343-1356. PubMed ID: 37823726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis.
    Zhang J; Liu Y; Li Q; Zuo L; Zhang B; Zhao F; Fan F; Luo S; Hu Y; Sun C
    Carcinogenesis; 2023 May; 44(3):242-251. PubMed ID: 36999754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hema-seq reveals genomic aberrations in a rare simultaneous occurrence of hematological malignancies.
    Jeong D; Lee AC; Shin K; Kim J; Ham MH; Lee C; Lee S; Choi A; Ryu T; Kim O; Jung Y; Kwon S; Lee DS
    Cell Rep Methods; 2023 Oct; 3(10):100617. PubMed ID: 37852254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation effects of radiation and ferroptosis on tumor suppression and radiation injury.
    Su J; Bian C; Zheng Z; Wang H; Meng L; Xin Y; Jiang X
    Front Cell Dev Biol; 2022; 10():951116. PubMed ID: 36176274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells.
    Liang L; Liu Y; Wu X; Chen Y
    Int J Med Sci; 2023; 20(12):1535-1550. PubMed ID: 37859702
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic role of controlling nutritional status score in hematological malignancies.
    Zhang Y; Chen Q; Lu C; Yu L
    Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
    Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
    Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinases in hematological malignancies.
    Lei H; Wang J; Hu J; Zhu Q; Wu Y
    Biomark Res; 2021 Aug; 9(1):66. PubMed ID: 34454635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.